T0	Participants 67 118	premenopausal patients with advanced breast cancer.
T1	Participants 134 157	122 premenopausal women
T2	Participants 221 350	54 evaluable women treated with tamoxifen, 24% had an objective response, as compared with 21% of 53 women having an oophorectomy
T3	Participants 573 584	58 patients
T4	Participants 778 797	premenopausal women